ActoGeniX raises €13.5 million
ActoGeniX, a Dutch drug company whose lead candidate is focused on inflammatory bowel disease, has raised €13.5 million in second-round funding.
Actifio, a Waltham, Mass.-based provider of data management virtualization, has raised $8 million in Series A funding co-led by North Bridge Venture Partners and Greylock Partners.